To receive the Audited Financial Statements for the financial year ended 31 December 2020 together with the Reports of the Directors and Auditors.

To re-elect Dato' Sri Mohammed Shazalli Ramly, who retires in accordance with Article 123 of the Company's Constitution.

To re-elect Datuk Zulkarnain Md Eusope, who retires in accordance with Article 123 of the Company's Constitution.

To re-elect Dato' Dr. Najmil Faiz Mohamed Aris, who retires in accordance with Article 123 of the Company's Constitution.

To re-elect Datuk Dr. Azhar Ahmad, who retires in accordance with Article 123 of the Company's Constitution.

To re-elect Zulkifli Jafar, who retires in accordance with Article 123 of the Company's Constitution.

To re-elect Dr. Abdul Razak Ahmad, who retires in accordance with Article 123 of the Company's Constitution.

To re-elect Izaddeen Daud, who retires in accordance with Article 123 of the Company's Constitution.

To re-elect Zainal Abidin Shariff, who retires in accordance with Article 123 of the Company's Constitution.

To approve payment of Directors' fees and meeting allowances for Pharmaniaga Berhad from 17 June 2021 until the conclusion of the next AGM of the Company.

To approve payment of meeting allowances to Directors for directorship in Pharmaniaga Berhad subsidiaries in Malaysia from 17 June 2021 until the conclusion of the next AGM of the Company.

To approve payment of Directors' fees and meeting allowances to Directors for directorship in Pharmaniaga Berhad subsidiaries in Indonesia from 17 June 2021 until the conclusion of the next AGM of the Company.

To approve the payment of benefits in kind payable to the Chairman and Directors from 17 June 2021 until the conclusion of the next AGM of the Company.

To re-appoint Messrs. PricewaterhouseCoopers PLT as auditors of the Company and to hold office until the conclusion of the next AGM, at a remuneration to be determined by the Directors.

Authority to allot and issue shares in general pursuant to Sections 75 and 76 of the Companies Act 2016.

Proposed Renewal of Shareholders' Mandate for Recurrent Related Party Transactions.